Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCNK | O75909 | 2/20 | 0.68 |
| ▸ | CDK12 | Q9NYV4 | 2/20 | 0.68 |
| ▸ | CDK1 | P06493 | 3/20 | 0.64 |
| ▸ | CDK2 | P24941 | 14/20 | 0.58 |
| ▸ | CCNA2 | P20248 | 11/20 | 0.58 |
| ▸ | CCNA1 | P78396 | 11/20 | 0.58 |
| ▸ | CDK5 | Q00535 | 7/20 | 0.58 |
| ▸ | CDK5R1 | Q15078 | 7/20 | 0.58 |
| ▸ | DYRK1A | Q13627 | 6/20 | 0.58 |
| ▸ | CCNE1 | P24864 | 4/20 | 0.56 |
| ▸ | CCNE2 | O96020 | 3/20 | 0.56 |
| ▸ | CDK9 | P50750 | 2/20 | 0.50 |
| ▸ | CDK4 | P11802 | 1/20 | 0.50 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.50 |
| ▸ | CCND1 | P24385 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | CDK7 | P50613 | 1/20 | 0.50 |
| ▸ | CCNH | P51946 | 1/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25311650 | 0.90 | CDK1 (0.64) | CCNKCDK12CDK1CDK2CCNA2 | |
| SCHEMBL25262363 | 0.84 | CCNK (0.63) | CCNKCDK12CDK1CDK2CCNA2 | |
| SCHEMBL30518519 | 0.84 | CCNK (0.63) | CCNKCDK12CDK1CDK2CCNA2 | |
| SCHEMBL3696802 | 0.83 | CDK1 (0.75) | CCNKCDK12CDK1CDK2CCNA2 | |
| SCHEMBL3859252 | 0.83 | CDK1 (0.78) | CDK1CDK2CCNA2CCNA1CDK5 | |
| SCHEMBL25309464 | 0.81 | CDK1 (0.60) | CCNKCDK12CDK1CDK2CCNA2 | |
| SCHEMBL6152647 | 0.81 | CDK1 (0.82) | CDK1CDK2CCNA2CCNA1CDK5 | |
| SCHEMBL17628615 | 0.79 | CDK1 (0.87) | CCNKCDK12CDK1CDK2CCNA2 | |
| SCHEMBL31072401 | 0.79 | CDK1 (0.79) | CDK1CDK2CCNA2CCNA1CDK5 | |
| SCHEMBL28459824 | 0.79 | CDK1 (0.79) | CDK1CDK2CCNA2CCNA1CDK5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250101023-A1 | HETEROARYL DERIVATIVE AND USES THEREOF | IUCF-HYU (INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY) (KR) | 2025-03-27 | — | — | US | disclosed |
| WO-2023140640-A1 | HETEROARYL DERIVATIVE AND USES THEREOF | 한양대학교 산학협력단 | 2023-07-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250101023-A1 | HETEROARYL DERIVATIVE AND USES THEREOF | ERBB2, ERBB3, FGFR2 | CCNK 1801/4885CDK12 2419/4885CDK1 2784/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.